440 karma · joined June 9, 2019
If I remember correctly, there's over a hundred various amino acids. For humans, we have only 20.
Fun fact: ~5% of health care costs come from physician salaries, 8% is from nurses.
What is notable about Ebola is that its virulence keeps dropping while its ability to spread has significantly increased. The larger issue is that Ebola is in areas that don't have the resources to handle any serious outbreak. It's becoming more likely that Ebola is going to be self sustaining soon.
I'm kind of amazed that a comment expressing interest in when this therapy will be obsolete, see that 96% of bacteria are resistant to Penicillin G now, gets a negative response. Drugs are only effective when the pathogen is still sensitive to them.
Fahrenheit 451 is also a solid read.
If Apple replaces only the keyboard, the MBP is the undisputed best laptop available today.
Further reading: https://www.health.harvard.edu/diseases-and-conditions/the-l...
>DNA dictates whether a protein can be expressed or not, but not whether it is expressed in any particular cell, how much is expressed, or whether and how much is activated or otherwise modified over time.
It does determine whether it is expressed and how much is expressed. The difference between being a heterzygote and homozygote for certain proteins literally determines whether one will have fully protein expression or half. When a gene is doubled in the genome its expression is usually doubled as well.
>Because there are cases (probably the majority) where drug-gene interaction is insufficient.
80-90% of drugs are metabolized by CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP3A5 to which we are starting to isolate polymorphisms in the general public. This isn't that difficult to do the genotyping, but what's limited right now is correlating polymorphism to what the side effect of drug is; this is going to be purely a time and data collection issue. I'm curious what your examples would be, because the majority of cases I've been apart of it's a simple base pair substitution that cause deleterious effects.
Yes, pharmacogenomics is a home run on straight forward cases, but the amazing thing is that straight forward cases are the most important for medicine. Drug-gene interactions are so unbelievably basic and require next to zero know how to correlate side effects to genes. My previous example of genomics not being lucid is in intelligence because we have zero idea what makes someone intelligent on a molecular level, which physicians could not care less about.
My final point is purely on practicality. Last I had heard, there are some hospital systems that have genome sequencing are down to tens of dollars and are done in under an hour or two. Isolating a single protein, looking at its expression, and assaying activity is not only the bane of every biochemists existence, it takes a significant amount of time and would have to be done for every single enzyme that we want to look at. We have to be practical in medicine and the most practical option for the foreseeable future, unless a CRISPR like breakthrough comes along, is going to be genome sequencing.
Now, what is going to be absolutely insane in the field of proteomics is when we can accurately predict a protein's structure and then make novel drugs to enhance or inhibit said protein. I can't remember how many amino acids it is before we're unable to predict the structure of a protein, but it's low and the current method to look at protein structure is stupid hard. Obnoxiously hard; I don't even want to talk about it but it's hard and you have to send your samples to a handful of locations. We use super computers at the moment to elucidate small proteins and usually they suck bad at doing it. If we were able to accurately predict structure and function of a novel protein with computer models, use CRISPR to insert the gene into a genome for said protein we are talking about increasing human life span in a logarithmic fashion.
Now what makes drug metabolism easy to understand is that it will typically be one gene that codes for one enzyme (I'm overly simplifying this here, it's way more complicated and we don't fully understand gene expression). It will also usually be one enzyme that is going to break down a certain drug (I'm also oversimplifying this). Let's look at ethanol; it's broken down by alcohol dehydrogenase to acetaldehyde, the thing that gives you the hang over. Certain populations, Asian and Native Americans namely, have a different alcohol dehydrogenase enzyme than other populations and thus have a common effect; colloquially termed Asian flush. This variability in how an enzyme breaks down a drug is part of the reason why some people will have certain effects whereas other people won't (overly simplified, again). Pharmacogenomics is actually one of the more easy phenotypes to delineate versus other, more nebulous, things.
What's going to also happen that mainstream media has failed to grasp the gravity of is pharmacogenomics/pharmacogenetics. Essentially what we are going to do the second you enter the ED/PCP/PreOP is sequence your DNA. Then we will tailor your drug regime based on your phenotype (What traits/characteristics you have expressed). This kind of thing was just imaginary, but last year I listened to one of the world's leading pediatric pharmacogenomicists that had a half dozens cases he shared; one of them was having a 16 y/o female that presented with depression that was not ameliorated with first line SSRI. Upon sequencing her genome they realized that her phenotype was incompatible with this SSRI, switched her and upon 4 week followup her symptoms were significantly reduced.
The 20th century was the century of physics, the 21st will be the century of biology.